November 3, 2022 — Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that it is developing the MEVION S250-FIT Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS).

The industry is seeing a sense of momentum from industry leaders to help expand lung screening programs

The pace of new lung cancer screening initiatives, published research and collective efforts of organizations and imaging specialists in the United States and across the world has, impressively, quickened. While Lung Cancer Awareness Month is officially on the calendar in November, the work of a broad, committed range of focused experts is a daily priority.
The FDA’s outlined framework and action plan are steps in the right direction, but we need to ensure that inaction or delayed response in addressing regulation of AI and ML do not stall innovation

After lagging other sectors for years, the era of artificial intelligence (AI) in healthcare is dawning as its use is becoming more prevalent in a variety of applications — from medical imaging and ophthalmology, to remote monitoring and leveraging electronic health records (EHRs) to identify potential risk for chronic diseases or complications.

Jenny Dunkley, Director of CVIT Product Marketing, GE Healthcare

Submitted by mtaschetta-millane on Wed, 11/02/2022 - 17:45

November 2, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced results from its Phase 3 SPOTLIGHT trial that evaluated the impact of various clinical factors

November 2, 2022 — At the Radiological Society of North America’s 2022 annual meeting (RSNA), international medical imaging and cybersecurity company Sectr

The FDA, AMA and CAP are finally beginning to align, with sights set firmly on a digital future

In this digital age it may come as a surprise that in one of the most advanced healthcare markets in the world, primary pathological diagnosis remains conducted by pathologists peering down the lens of a microscope.

The fixed digital radiography (DR) rooms market experienced strong growth in 2021, with 15% growth in revenue reported, with revenues estimated at $1.2 billion. Likewise, the fluoroscopy X-ray market returned to growth after a year of retraction in demand in 2020, with 18% year-on-year growth in 2021, with an estimated market size of $509 million.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now